Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021
Freya Hogarth, Pasqualina Coffey, Laura Goddard, Sarah Lewis, Shereen Labib, Mathilda Wilmot, Patiyan Andersson, Norelle Sherry, Torsten Seemann, Benjamin P. Howden, Kevin Freeman, Robert Baird, Ian Hosegood, Kathleen McDermott, Nick Walsh, Ben Polkinghorne, Catherine Marshall, Jane Davies, Vicki Krause, and Ella M. Meumann
Author affiliations: Australian Government Department of Health, Canberra, Australian Capital Territory, Australia (F. Hogarth); The Australian National University, Canberra (F. Hogarth, B. Polkinghorne); Centre for Disease Control, Darwin, Northern Territory, Australia (P. Coffey, L. Goddard, S. Lewis, S. Labib, V. Krause); The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (M. Wilmot, P. Andersson, N. Sherry, T. Seemann, B.P. Howden); Royal Darwin Hospital, Darwin (K. Freeman, R. Baird, C. Marshall, J. Davies, E.M. Meumann); Qantas Airways Limited, Mascot, New South Wales, Australia (I. Hosegood); National Critical Care and Trauma Response Centre, Darwin (K. McDermott, N. Walsh); Menzies School of Health Research and Charles Darwin University, Darwin (J. Davies, E.M. Meumann)
Main Article
Figure
Figure. Schematic showing genomic clusters and in-flight transmission of SARS-CoV-2 on 2 flights from India to Australia, April 2021.
Main Article
Page created: April 28, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.